SCHEMBL5249263

SCHEMBL5249263

CCNC(=O)c1ccc(-n2nnc(C(=O)NCc3cccc(-c4ccc(F)cc4)c3)c2CSC)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
CCR1 P32246 5/20 0.42
SMO Q99835 1/20 0.41
CYP2C9 P11712 3/20 0.41
AOC3 Q16853 2/20 0.41
ROCK2 O75116 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
ROCK1 Q13464 2/20 0.41
IDO1 P14902 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
HTR2C P28335 1/20 0.39
MCHR1 Q99705 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5244366 0.91 CCR1 (0.45) LMNACCR1ROCK2ALDH1A1
SCHEMBL5244456 0.89 LMNA (0.57) LMNASMOALDH1A1HDAC1
SCHEMBL5249308 0.86 RIPK1 (0.46) LMNACCR1SMOCYP2C9ROCK2
SCHEMBL5248174 0.85 POLB (0.48) LMNACCR1CYP2C9CYP3A4CYP2D6
SCHEMBL5246022 0.85 CCR1 (0.43) LMNACCR1CYP2C9ROCK2CYP3A4
SCHEMBL5246361 0.85 CCR1 (0.49) LMNACCR1ROCK2HDAC1
SCHEMBL5244694 0.85 HPGD (0.48) LMNACYP2C9ROCK2ROCK1ALDH1A1
SCHEMBL5244318 0.85 CCR1 (0.59) CCR1CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL5245295 0.85 LMNA (0.44) LMNACCR1SMOCYP2C9ROCK2
SCHEMBL5246674 0.84 ROCK2 (0.53) LMNACCR1CYP2C9ROCK2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867331-A1 TRIAZOLE DERIVATIVE AND THE USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-12-19 EP disclosed